| __timestamp | Bausch Health Companies Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 2254600000 | 179279000 |
| Thursday, January 1, 2015 | 2645000000 | 186359000 |
| Friday, January 1, 2016 | 2611000000 | 171785000 |
| Sunday, January 1, 2017 | 2548000000 | 208136000 |
| Monday, January 1, 2018 | 2351000000 | 198405000 |
| Tuesday, January 1, 2019 | 2350000000 | 224169000 |
| Wednesday, January 1, 2020 | 2249000000 | 245044000 |
| Friday, January 1, 2021 | 2394000000 | 252314000 |
| Saturday, January 1, 2022 | 2364000000 | 268225000 |
| Sunday, January 1, 2023 | 2559000000 | 304629000 |
| Monday, January 1, 2024 | 324203000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. From 2014 to 2023, Bausch Health Companies Inc. and Taro Pharmaceutical Industries Ltd. have shown distinct trends in their cost of revenue. Bausch Health's cost of revenue has fluctuated, peaking in 2015 with a 17% increase from 2014, before stabilizing around 2.4 billion USD in recent years. In contrast, Taro Pharmaceutical has seen a steady rise, with a notable 70% increase from 2014 to 2023, reaching approximately 304 million USD. This divergence highlights Bausch's larger scale and operational complexity compared to Taro's more streamlined approach. The data for 2024 is incomplete, indicating potential shifts in the coming year. These insights provide a window into the strategic financial management of these pharmaceutical giants, offering valuable lessons for investors and industry analysts alike.
AbbVie Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Novartis AG and Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: Pharming Group N.V. and Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Bausch Health Companies Inc. vs Mesoblast Limited
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.